Developing a global framework to assess a country's readiness and resilience to introduce a new vaccine or improve uptake of an underutilized vaccine.
Journal article
Monk V. et al, (2026), Expert Rev Vaccines, 25
Parental motivations, facilitators, and barriers to participating in a pediatric vaccine trial in Kathmandu, Nepal: A qualitative study.
Journal article
Firth C. et al, (2026), Hum Vaccin Immunother, 22
Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults-A Pilot Study.
Journal article
Alsaleh G. et al, (2026), Aging Cell, 25
In silico post-hoc analysis of a clinically tested recombinant West Nile virus envelope protein vaccine.
Journal article
Reiné J. et al, (2026), Comput Biol Chem, 122
Host-microbial interactions at the nasal mucosa in young children and adults: A retrospective, cross-sectional study.
Journal article
Reiné J. et al, (2026), Cell Rep, 45
Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections: a secondary analysis of observational data.
Journal article
Hagedoorn NN. et al, (2026), Vaccine, 85
Antibody fine specificity correlates with protection from malaria for the RTS,S vaccine in young African children: A post hoc analysis of a phase IIb randomised controlled trial.
Journal article
Hysa A. et al, (2026), PLoS Med, 23
National Cross-Sectional Study Assessing the Positivity Rate and Clinical Manifestations of Human Bocavirus Respiratory Infections Among Hospitalized Children Under 5 Years of Age in Jordan
Journal article
Abu Lubad M. et al, (2026), Pathogens, 15, 515 - 515
The impact of the COVID-19 pandemic on healthy volunteer motivations: a mixed-methods study of participants in plague vaccine trials in the UK and Uganda.
Journal article
Stuart AS. et al, (2026), BMC Public Health
Willingness to accept paediatric blood sample collection for clinical research purposes in Nepal: a qualitative study.
Journal article
Dahal A. et al, (2026), BMJ Glob Health, 11
Predicting trajectories of illness using RNA velocity of whole blood.
Journal article
Dunican C. et al, (2026), Nat Commun, 17
Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trial.
Journal article
Thorn N. et al, (2026), Lancet Infect Dis
Effect of 13-valent pneumococcal conjugate vaccine on experimental carriage at 1-year post-vaccination on rechallenge with Streptococcus pneumoniae serotype 6B in Blantyre, Malawi: a controlled human infection study and longitudinal follow-up of a randomised controlled trial.
Journal article
Chirwa AE. et al, (2026), Lancet Microbe, 7
"Intranasal vaccination with recombinant human adenovirus encoding the trans-sialidase gene protects mice from lethal subcutaneous and oral Trypanosoma cruzi trypomastigote challenges".
Journal article
Noronha IH. et al, (2026), J Infect Dis
Evaluation of Salmonella Paratyphi specific antibody quantity and function after vaccination and controlled human infection.
Journal article
Jones E. et al, (2026), J Immunol, 215

